Abatacept/Tacrolimus or Abatacept/Tacrolimus/Post-Transplant Cyclophosphamide Are Safe and Highly Effective in Preventing Graft-Versus-Host Disease in Matched or Mismatched Donor Peripheral Blood Stem Cell Transplantation

被引：1
|
作者：
Vorobyev, Vladimir I. [1 ]
Subora, Anton Yu. [1 ]
Oleinik, Yulia A. [2 ]
Butaev, Lev S. [1 ]
Zherebtsova, Vera A. [1 ]
Kisilichina, Darya G. [1 ]
Ulyanova, Margarita A. [1 ]
Urnova, Evdokiya S. [1 ]
Sukhareva, Alena M. [1 ]
Bulusov, Matvei P. [1 ]
机构：
[1] Botkin Hosp, Bone Marrow Transplant, Moscow, Russia
[2] Botkin Hosp, Moscow, Russia
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-168542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7622 / 7623
页数：2
相关论文
共 50 条
  • [1] Post-Transplant Cyclophosphamide, Abatacept, and Short Course of Tacrolimus Combination (CAST) Is Safe and Seems Highly Effective in Preventing Graft-Versus-Host Disease Following Haploidentical Peripheral Blood Stem Cell Transplantation
    Al-Homsi, A. Samer Samer
    Cirrone, Frank
    Cole, Kelli
    Stocker, Kelsey
    Bruno, Benedetto
    Suarez-Londono, J. Andres
    Goldberg, Judith
    Abdul-Hay, Maher
    [J]. BLOOD, 2021, 138
  • [2] Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation
    Al-Homsi, A. Samer
    Cirrone, Frank
    Cole, Kelli
    Suarez-Londono, Jaime Andres
    Gardner, Sharon L.
    Hsu, Jingmei
    Wo, Stephanie
    Stocker, Kelsey
    Bruno, Benedetto
    Goldberg, Judith
    Levinson, Benjamin
    Abdul-Hay, Maher
    [J]. BLOOD, 2022, 140 : 7628 - 7630
  • [3] Post-transplant cyclophosphamide, abatacept, and short course of tacrolimus (cast) for graft-versus-host disease prevention following haploidentical hematopoietic stem cell transplantation
    Al-Homsi, A. S.
    Cirrone, F.
    Cole, K.
    Stocker, K.
    Bruno, B.
    Suarez-Londono, J. A.
    Gardner, S.
    Goldberg, J.
    Hay, M. Abdul
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 198 - 199
  • [4] Abatacept acute graft-versus-host disease prophylaxis is feasible and safe when combined with post-transplant cyclophosphamide in the mobilised peripheral blood haploidentical donor setting
    Yong, J.
    Patel, A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 290 - 290
  • [5] Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study
    Juarez, Alex
    Salas, Maria Queralt
    Pedraza, Alexandra
    Suarez-Lledo, Maria
    Rodriguez-Lobato, Luis Gerardo
    Solano, Maria Teresa
    Serrahima, Anna
    Nomdedeu, Meritxell
    Cid, Joan
    Lozano, Miquel
    Charry, Paola
    Arcarons, Jordi
    Llobet, Noemi
    Rosinol, Laura
    Fernandez-Aviles, Francesc
    Rovira, Montserrat
    Martinez, Carmen
    [J]. CANCERS, 2024, 16 (14)
  • [6] Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations
    Kunacheewa, Chutima
    Owattanapanish, Weerapat
    Jirabanditsakul, Chutirat
    Issaragrisil, Surapol
    [J]. CELL TRANSPLANTATION, 2020, 29
  • [7] Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation
    Al Malki, Monzr M.
    Bo-Subait, Stephanie
    Logan, Brent
    Olson, Janelle
    Leckrone, Erin
    Wu, Juan
    Stefanski, Heather E.
    Auletta, Jeffery J.
    Spellman, Stephen R.
    Malmberg, Craig
    Shaffer, Brian C.
    Modi, Dipenkumar
    Khimani, Farhad
    Gooptu, Mahasweta
    Hamadani, Mehdi
    Broglie, Larisa
    Shaw, Bronwen E.
    Devine, Steven Michael
    Jimenez, Antonio Martin Jimenez
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation
    Pedraza, Alexandra
    Jorge, Sofia
    Suarez-Lledo, Maria
    Pereira, Arturo
    Gutierrez-Garcia, Gonzalo
    Fernandez-Aviles, Francesc
    Rosinol, Laura
    Llobet, Noemi
    Solano, Teresa
    Urbano-Ispizua, Alvaro
    Rovira, Montserrat
    Martinez, Carmen
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (07): : 619.e1 - 619.e8
  • [9] Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial
    Popat, Uday R.
    Mehta, Rohtesh S.
    Bassett, Roland
    Alousi, Amin M.
    Alatrash, Gheath
    Bashir, Qaiser
    Hosing, Chitra
    Im, Jin S.
    Kebriaei, Partow
    Kawedia, Jitesh D.
    Khouri, Issa F.
    Marin, David
    Nieto, Yago
    Olson, Amanda L.
    Oran, Betul
    Ramdial, Jeremy L.
    Saini, Neeraj
    Srour, Samer A.
    Valdez, Benigno C.
    Rezvani, Katayoun
    Qazilbash, Muzaffar H.
    Kadia, Tapan M.
    Kantarjian, Hagop
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Andersson, Borje S.
    [J]. BLOOD, 2021, 138 : 1803 - +
  • [10] Graft-Versus-Host Disease (GvHD) Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation (haplo-PBSCT) Using Abatacept in Combination with Post-Transplant Cyclophosphamide (PTCy)
    Kaur, Sukhdeep
    Gelman, Simon
    Rowley, Scott
    Baker, Eliana
    Baker, Melissa
    Suh, Hyung C.
    Cho, Christina
    Donato, Michele L.
    [J]. BLOOD, 2023, 142
12345